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The classical opsonins C3 and IgG bind to microorganisms and facilitate phago-
cytosis. Recent work suggests that additionalproteins may also have opsonic activity.
The acute-phase reactant, C-reactiveprotein (CRP), binds to phosphocholine residues
on gram-positive bacteria and facilitates their interaction with phagocytes (1). An-
other acute-phase reactant, mannose binding protein (MBP),' binds to mannose
residues on bacteria and fungi and facilitates recognition by phagocytes (2). We have
investigated a third recently discovered acute-phase reactant, lipopolysaccharide
binding protein (LBP) (3). LBP is a 60-kD glycoprotein present at concentrations
<100 ng/ml in the serum of healthy rabbits. During the acute phase, LBP is synthe-
sizedby hepatocytes (Ramadori, G., K.-H. Meyer zum Buschenfelde, P S. Tobias,
J. C . Mathison, and R. J . Ulevitch, manuscript submitted for publication), and
reaches concentrations of 30-50 Fig/ml in serum. Here we show that LBP binds to
LPS on the surface of bacteria and to LPS inserted into erythrocyte membranes.
Binding of LBP to these particles dramatically enhances their interaction with mac-
rophages. Particle-bound LBP is recognized by a receptor that is mobile in the plane
of the membrane and that appears distinct from other opsonic receptors.
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Materials and Methods
Reagents.
￿
LBP was purified from acute-phase rabbit serum (3), and appeared homoge-
neous on silver-stained gels. Anti-rabbit LBP was raised in goats. MBP was a gift of Dr.
R. A. B. Ezekowitz (Harvard Medical School, Boston, MA). Bactericidal/permeability-
increasing factor (BPI) was a generous gift of Dr. J. Gabay (Cornell Medical College, New
York, NY). LPS from Salmonella minnesota (Re595 or wild type) was obtained from List Bio-
logical (Campbell, CA). mAbs IB4 against CD18 and 3G8 against Fc-YRIII (CD16) were as
described (4); mAb 543 against CRI was a gift of Dr. R. Schreiber (Washington University,
St. Louis, MO); and mAbs 22 and IV.3, against FcyRI and Fc-yRII, were gifts from Dr.
M. Fanger (Dartmouth Medical School, Hanover, NH). Pyrogen-free human serum albumin
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(HSA) was from Armour Pharmaceutical Co. (Tarrytown, NY); and pyrogen-free PBS and
DGVBZ' were from Whitaker MA Bioproducts (Walkersville, MD). NHS-biotin, Sulfo-
NHS-biotin, and streptavidin were from Pierce Chemical Co. (Rockville, MD).
Surfaces.
￿
Tissue cultureplastic surfaces were coated by incubation with 25 14g/ml protein
(antibody, LBP, or HSA) or 1 14g/ml LPS for1 hat 20*C. To form immune complexes, HSA-
coated surfaces were incubated with anti-HSA antiserum (1 :50) for an additional 30 min.
In some cases, LPS-coated surfaces were subsequently treated with 10 ttg/ml LBP for30 min
at 20 °C. For assays of hydrogen peroxide production, all coated surfaces were exposed to
1 mg/mlHSA for 1 hbefore theaddition ofphagocytes. Coated surfaces were carefullywashed
with pyrogen-free PBS before the assays.
Cells.
￿
Monocyte-derived macrophages(MO) were obtained by culturingpurified human
monocytes in Teflon beakers for3-10 d as described (5). Monolayers offreshmonocyteswere
obtained by allowing PBMC to adhere to protein-coated plastic for45 min at 37°C. PBMC
were purified from fresh bloodby the method ofEnglishand Anderson (6). T cells, purified
by rosetting with E, were a gift ofJ. Ming (The Rockefeller University). Human umbilical
vein endothelial cell monolayers (7)were agift ofDr. S. K. Lo (The Rockefeller University).
Sheep Ewere coated with IgG(EIgG) or IgM(EIgM) as described(5). C3bi wasdeposited
on EIgM by incubating 2-10 x 108 EIgM in 1 ml of 10°Jo C5-deficient human serum (Sigma
Chemical Co., St. Louis, MO) for 30 min at 37°C. The erythrocytes were then washed and
incubated for 10 min at 0°C in an EDTA-containing buffer. The resulting EC3bi bore no
C3b as assayed by EDTA-resistant rosetting with MO. Ewere coated with LPS as described
(8). The amount of LPS used in the preparation was varied to yield ELPSh' (1-10 hg/4 x
107 E) or ELPS'° (0.2-1 Rg/4 x 10' E). ELPS'o were coated with LBP by incubating equal
volumes of ELPS'° (108/ml) and LBP (10 ug/ml) for 20 min at 37°C. The resulting LBP-
coated ELPS were washed and used immediately.
For certain experiments, E were also coated with LBP by an alternative method. E were
first biotinylated by incubating 5 x 108 E with 250 Rg Sulfo-NHS-biotin for 20 min at 5°C
in 0.1 M sodium carbonate, pH 9.2, and LBP was biotinylated by incubating 50 lAg LBP
with 5 Wg Sulfo-NHS-Biotin and dialyzing against PBS. The biotinylated protein was then
linked to the biotinylated E through a streptavidin bridge. 108 washed, biotinylated E (EB)
were incubatedwith 101Agstreptavidin for30 minat 20°C to yield avidin-coated erythrocytes
(EBAV). Preliminary experiments using fluoresceinated streptavidin showed that the EBAV
were uniformly and intensely fluorescent, and no agglutination could be seen. 2.5 x 107
washed EBAV were incubated with 2.5 hg of biotinylated LBP for 30 min at 20°C to yield
EBAVLBP
Salmonella typhimurium.
￿
LT2 Gal E was grown in the presence or absence of galactose to
yieldcellswith a complete or truncatedLPS, respectively (8). Exponentially growingcultures
were washed, labeled with fluorescein, and adjusted to 2 x 108/ml in PBS as previously de-
scribed (8).
Assays.
￿
Agglutination of LPS-coated erythrocytes was measured by shaking 106 ELPSh'
in 10 pl ofdiluted LBP for 30 min at 21'C in a round-bottomed microtest plate. Agglutina-
tion was read from the settling pattern.
Binding of ligand-coated E to MO was measured as described (5). Briefly, Terasaki tissue
culture plates were coated with HSA or other proteins (see above), and monolayers of MO
were established by incubating 5 Al of cells (0.5 x 106/ml in PBS containing 3 mM glucose,
0.5 mg/ml HSA, and 0.3 U/ml aprotinin [Sigma Chemical Co.])for 45 min at 37°C. Ligand-
coated E and the indicated proteins were added to the monolayers. E were allowed to settle
for 10 min at 0°C, then the plate was warmed to 37°C for 15 min. Unattached E were re-
moved by washing and attachment was scored by phase contrast microscopy. Binding of
fluoresceinated Salmonella wasassessed by asimilar method usinga 15-min incubation at 37°C
as previously described (8). Results are reported as attachment index, the number of E or
bacteria per 100 MO. Phagocytosis of ligand-coated Ewas measured by similarmethods (5),
with theexception that incubation ofMO with the E wasfor45 min at 37°C, and uningested
E were lysed by briefexposure to hypotonic medium before scoring the wells. The attach-
ment or phagocytic index obtained by a fixed procedure varied substantially from day to
day. This variation prevented averaging of separate experiments, and representative experi-
ments are thus displayed.WRIGHT ET AL.
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Release of hydrogen peroxide during spreading of MO on coated surfaces was measured
as described (9). Briefly, 3-4 x 104 MO (day 3 or 4) were added to protein-coated tissue
culture wells containing horseradish peroxidase and 2.4 nmol of scopoletin. The plate was
incubated at 37 °C, and at intervals the consumption of scopoletin was measured using an
automated fluorescence plate reader. Results are averaged from hexaplicate wells and are
presented as nmol peroxide produced per well. Addition ofthe control stimulant, PMA (100
ng/ml), resulted in rapid evolution of peroxide that was identical in rate and extent for all
coated surfaces tested.
Results
LBP Binds to LPS Inserted into Erythrocyte Membranes.
￿
Addition of as little as 0.5
hg/ml of LBP to ELPShi caused agglutination. Since LPS partitions into the mem-
brane of E by hydrophobic interactions with phospholipids, this observation sug-
gests that LBP recognizes the exposed hydrophilic portion of the lipid A, and that
LBP has the potential to form multimers. The ELPS were not strongly agglutinated
and could be disrupted by gentle pipetting.
LBP Enhances Binding ofELPS and Salmonella to Macrophages.
￿
Gram-negative bac-
teria and LPS-coated erythrocytes bind to MO through an interaction of LPS with
members of the CD18 complex of receptors on leukocytes (8). We asked whether
the addition ofLBP could perturb that interaction. Initial experiments used E pre-
pared with high levels of LPS. These ELPSh' bound avidly to MO, and the addi-
tion of LBP slightly enhanced binding. To examine the nature of this enhancement,
E were prepared with low levels of LPS. ELPS'° were poorly bound by MO, but
the addition of LBP caused a dramatic enhancement of binding (Figs. 1 and 2).
Enhanced binding was dose dependent with a maximal effect at til Ag/ml LBP The
specificity of this effect is indicated by the observation that another acute-phase reac-
tant, mannose binding protein, did not affect binding of ELPS'° to MO (Fig. 2)
at concentrations as high as 100 FAg/ml (datanot shown); another LPS-binding pro-
tein, BPI, did not affect binding at concentrations as high as 10 hg/ml (not shown);
and polyclonal anti-LBP antiserum (1 :200) caused a 20-fold reduction in the roset-
ting of ELPS'° caused by LBP
The capacity of LBP to enhance interaction of ELPS with MO was also depen-
dent on the amount of LPS in the erythrocyte membrane (Fig. 3). LBP could effec-
tively mediate binding of E prepared with amounts of LPS 20-100-fold less than
the amount needed to sustain a direct interaction between ELPS and MO.
Strains of gram-negative bacteria that express a truncated LPS (rough strains)
are avidly bound by MO, but smooth strains, with a complete LPS, are bound poorly
(8). Since LBP binds equally well to both smooth and rough LPS (10), we asked
if LBP could opsonize smooth Salmonella. Addition of LBP caused a dramatic en-
hancement in the binding of smooth Salmonella to MO (Table I). Addition of LBP
also enhanced the binding of rough Salmonella, but the effect appeared less dramatic
due to the avid binding of unopsonized bacteria. Thus, LBP can enhance the inter-
action of a live bacterium with MO.
MO Recognize Complexes of LBP with LPS
￿
In the experiments above, LBP was
added together with the MO and the ELPS. To determine if LBP binds to MO or
ELPS, the cells were separately incubated with LBP, washed, and then combined.
Pretreatment of ELPS'° with LBP strongly enhanced binding to MO (Table II) with
a dose-response curve identical to that observed in the coincubation experients (data1234
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FIGURE 1 .
￿
LBP enhances the interaction of ELPS withMO. Monolayers ofMO were incubated
with ELPS" in the absence (top) or presence (bottom) of 5 Wg/ml LBP. The monolayers were
washed, fixed with glutaraldehyde, and photographed with phase contrast illumination .E L
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TABLE I
LBP Enhances Binding of Salmonella to MO .
LBP
￿
Smooth S. typhimurium
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FIGURE 2.
￿
LBP enhances the interaction
of ELPS with MO. Monolayers of MO
were incubated with E or ELPSI° in the
presence ofvarying doses of LBP, and at-
tachment index was scored. A control
acute-phase protein, MBP (5 jig/ml),
caused no enhancement of binding of
ELPS° (attachment index = 4.9). Re-
sults are representative offour separate ex-
periments.
FIGURE 3. LBP-dependent binding of
ELPS to MO depends on the density of
LPS in the E membrane. ELPS were pre-
pared with varying doses of LPS then in-
cubated with monolayers of MO in the
presence or absence of 5 ug/ml LBP.
Results are representative of four separate
experiments.
Rough S. typhimurium
1,096
2,109
Smooth and rough preparations ofS. typhimurium LT2 were obtained by grow-
ing GatE mutants of this strain in the presence or absence ofgalactose as described
(8). The binding of bacteria to monolayers of macrophages was then measured
in the presence or absence of 2.5 kg/ml LBP. Addition of LBP caused a 5 .9 ±
1.9 (n = 4)-fold enhancement in the binding of smooth bacteria to MO.
not shown). This result suggests that LBP associates stably with ELPS and that the
surface-bound LBP is recognized by MO. Pretreatment ofMO, on the otherhand,
did not affect the subsequent binding of ELPS (Table II).
LBP on the surface of ELPS is complexed with LPS. To determine if MO bind
to LBP in the absence ofLPS, LBP was biotinylated and attached to streptavidin-
coated erythrocytes. The resulting EBAVLBP were not bound by MO (Fig. 4), but
addition ofLPS caused strong attachment ofthe ELBP to MO. The LPS appeared
to enhance adherence of EBAVLBP by binding to LBP since the amount ofLPS
needed to cause attachment of ELBP was N50-fold less than needed to cause at-
tachment ofE lacking LBP (Fig. 4). Further, the LPS-treated ELBP bound avidly1236
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to CD18-deficient MO, whichdonot bind ELPS (datanot shown). Thus, LBPmust
be complexed with LPS in order to be recognized by MO.
LBPIs RecognizedbyaMobileReceptor Restricted toMononuclearPhagocytes.
￿
LBP-treated
ELPS bound to virtually 100% ofmonocytes and MO, suggesting that binding ac-
tivity is present on all members ofthese populations. To determine whether LBP
interacts with other cell types, monolayers ofPMN, T cells, and umbilical vein en-
dothelial cells were incubated with LBP-treated ELPS". No binding was observed
(data not shown). Similarly, lymphocytes that occasionally contaminate MO prepa-
rationswere never observed to bind LBP-coated E. Thus, the capacity to bind LBP-
coated particles appears to be a property restricted to mononuclear phagocytes.
The existence ofa specific receptor for LBP was demonstrated by allowing MO
to spread on surfaces coated with complexes of LPS and LBP Surface-bound LBP
strongly downmodulated binding of LBP-treated ELPSI° but had no effect on the
binding ofEIgG or EC3bi (Table III). These observations indicate that LBP is rec-
ognized by a molecule that is mobile in the plane of the membrane, and suggest
that this receptor is different from CR3 and FcR.
LBP Does Not Interact with CR3, or FcR.
￿
Since LPS is known to be recognized
by CR3 and other members of the CD18 complex (LFA-1 and p150,95) (8), it ap-
peared possible that LBP enhanced binding ofELPS by facilitating the interaction
of a low amount of LPS with these receptors. Several observations, however, rule
out this possibility. LBP caused strong binding ofELPS to monocytes isolated from
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TABLE II
Pretreatment of ELPS But Not MO with LBP Enhances Their Interaction
Binding of ELPS" (0.2 tug/4 x 108 E) to monolayers of MO was measured as
described in Materials and Methods. ELPSI° or MO were pretreated at 37°C
with 5 t<g/ml LPB for 20 min and washed before the assay. Alternatively, 5,ug/ml
LBP was added during the assay of attachment.
O-O ELBP
"- " EBAV
O
0.0
￿
0.1
￿
0.2
￿
0.3
LPS added (leg/ml)
FIGURE 4.
￿
MO do not recognize LBP in
the absence of LPS. E-coated with biotin
and streptavidin alone (EBAV) were in-
cubated with biotinylated LBP to yield
ELBP. Both ELBP and EBAV were in-
cubated with graded doses of LPS for 20
min at 37'C, washed, and binding to
monolayers of MO was measured.
Condition Exp. 1
Attachment Index
Exp. 2 Exp. 3
No LBP 6 17 4
Pretreat ELPS" 820 715 942
Pretreat MO 5 21 16
Coincubate LBP, ELPSI°, and MO 629 520 796WRIGHT ET AL.
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TABLE III
Receptorsfor LBP Are Mobile in the Plane of the Membrane
Plastic surfaces were coated with HSA (500 t~g/ml), mAb IB4 (25 jug/ml), or
LPS (1 tag/ml) for 2 h at 21°C and washed thoroughly. Where indicated, anti-
HSA (1 :40 dilution of rabbit anti-HSA antiserum) or LBP (5 tag/ml) was added
and incubated for 30 min at 20°C. MO were allowed to spread on the washed,
coated surfaces for 45 min at 37°C, and after an additional wash, the ligand-
coated E were added. ELpShi were prepared with 3 ug LPS/4 x 10' E. ELPS'°
were prepared with 0.3 tag LPS/4 x 107 E then treated with 5 tag/ml LBP as
described in Materials and Methods. Data shown are representative of four
separate experiments.
two patients with a congenital deficiency ofCD18 (Table IV). As expected, the CD18-
deficient cells exhibited negligible binding of ELpShi or EC3bi in parallel assays.
Further evidence against the participation of CD18 molecules in recognition of LBP-
treated ELPSI° comes from experiments in which CD18 molecules were depleted
from the apical surface of MO by allowing them to spread on surfaces coated with
anti-CD18 mAbs. mAb 1134 downmodulated CD18 molecules as shown by the de-
creased binding of EC3bi and ELPSh', but LBP-treated ELPSI° bound normally to
these cells (Table III). Finally, depletion of Ca2+ and Mg2+ completely blocks
binding of both C3bi and LPS to the CD18 complex (5, 8), but binding of LBP-
treated ELPSI° was equivalent in EDTA-containing buffers (data not shown).
The participation of Fc receptors in the recognition LBP was also ruled out.
Spreading of cells on an immune-complex coated surface strongly downmodulated
Fc receptorsas assayedby thebindingof EIgG. However, thebindingof LBP-coated
ELPSI° was unaffected (Table III). Similar studies showed that surface-bound man-
nose binding protein and surface-bound mAbs against FcRI, FcRII, FcRIII, and
TABLE IV
LBP Mediates Binding of ELPSI° to Monocytes from
CD18-deficient Patients
Monolayers ofmonocytes from two CD18 deficient patients (Wright, S. D., P. A.
Detmers, R. Adamowski, L. G. Kabbash, and M. Pabst, manuscript in prepa-
ration) and two normal adult controls were incubated with EC3bi, ELpShi
(3ug/4 x 1OsE), ELPSI° (1 tag/4 x 108 E), and attachment index was measured.
Where indicated, 2.5 lag/ml LBP was added with the ELPSI°.
Subject ELpShi
Attachment
ELPSI°
index
ELPSI°
+ LBP EC3bi
Control 1 108 31 282 129
Control 2 185 27 437 162
Patient 1 17 15 394 4
Patient 2 5 14 529 16
Surface
ELPS'°
+ LBP ELpShi EC3bi EIgG
HSA 833 507 915 621
HSA-anti-HSA 795 455 1,051 45
IB4 846 149 200 253
LPS-LBP 147 628 1,161 7621238
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CRI had no effect on the binding of LBP to MO (not shown) . These data suggest
that LBP is not recognized by CRI, CR3, FcRor mannose binding protein receptors .
ReceptorsforLBPEnhance Fc-mediated Phagocytosis .
￿
Addition of anti-E IgG caused
LBP-coated ELPS° to be avidly phagocytosed byMO (Fig . 5) . The dose of anti-E
IgG needed for half-maximal phagocytosis was fivefold less than that needed to in-
duce phagocytosis of uncoated E (Fig . 5) . LBP thus appears to act synergistically
with IgG to induce a phagocytic response . In keeping with previous reports (11),
deposition of C3bi on E also enhanced phagocytosis mediated by IgG, and the ex-
tent of this enhancement was similar to that caused by LBP (Fig. 5) .
We also measured phagocytosis mediated by LBPalone . Though LBP-coated ELPS
formed florid rosettes with M0, none of the bound E were phagocytosed by either
resting (Fig. 5), fibronectin-, or PMA-stimulated MO (data not shown) . Parallel
studies showed strong fibronectin- and PMA-stimulated phagocytosis ofEMU A
possible explanation forthe absence of LBP-mediated phagocytosis is the high lateral
mobility of LPS on the surface of an erythrocyte . The LPS could "cap" on the pole
of the E attached to the MO, leaving insufficient ligand on the circumference of
theE to guide an advancing pseudopod . To prevent such capping, biotinylated LBP
was linked to biotinylated E proteins as described in Fig. 4 above . Again, none of
the E bound in this way were phagocytosed by either resting or PMA-stimulated
MO (phagocytic index = 0) . Parallel studies showed that E coated with biotinylated
F(ab)2 of an anti-CD18 mAb (IB4) were readily phagocytosed (phagocytic index =
482) . Thus, receptors for LBP cannot by themselves initiate phagocytosis of a coated
erythrocyte .
ReceptorsforLBPDoNot Initiate an 0xidatiae Burst.
￿
To determine whether interac-
tion ofLBP with its receptor initiates a cytotoxic response from MO, we measured
the production ofhydrogen peroxide during the interaction ofMO with coated sur-
faces (Fig . 6) . Surfaces coated with IgG antibody-antigen complexes caused brisk
release ofperoxide from macrophages . Surfaces coated with LBP or LBP-LPS com-
plexes, however, caused no release of peroxide above baseline . The failure to pro-
duce peroxide was not the result of inadequate interaction ofLBP with its receptor.
Binding to LPS-coated surfaces caused a small release ofperoxide (12% ofthat stimu-
lated by immune complexes or PMA), confirming that LPS was present on the sur-
face. Addition to LBP to LPS-coated surfaces blocked the release caused by LPS,
thus confirming that LBP effectively interacted with LPS in this experiment . Fi-
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FIGURE 5 . LBP enhances Fc-mediated
phagocytosis. Monolayers of MO (day 5
culture) were incubated for 45 min with
E, ELBP, or EC3bi in the presence of
varying dilutions ofanti-E IgG . Phagocy-
tosis oftheEwasdetermined as described
in Materials andMethods .ELBP wereob-
tained by adding 1 pg/ml LBP to ELPS"
(0 .3 wg LPS/4 x 10 7E) during incubation
with MO. Attachment of these E in the
absence of anti-E IgG was as follows: E,
attachment index (AI) = 0 ; EC3bi, AI =
417; ELBP, AI = 404 . Results are repre-
sentative of six separate experiments.LPS
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FIGURE 6. Secretion of hydrogen
peroxide during spreading of MO on
ligand-coated surfaces. 3 x 104 MO
(day 3 ofculture) were added to coated
microtiter wells and the evolution of
hydrogen peroxide wasmeasured at in-
tervals. Brisk production of peroxide
occurredduring spreadingon immune
complexes (HSA-anti-HSA,filledcircles)
or in response to the soluble agonist,
PMA (filled diamonds). Low but repro-
ducible peroxide release was observed
during interaction with LPS-coated
surfaces (open triangles). However,
spreading on LBP-coated surfaces (open
square) caused no release, and coating
ofLPS-coated surfaces with LBP (open
diamond) prevented the LPS-induced
generation ofperoxide. Results are the
average ofhexuplicate determinations
with standard error smaller than the
symbols.
nally, parallel experiments showed that spreading of MO on LBP or LPS+LBP-
coated surfaces caused down modulation of the binding of LBP-treated ELPSIO thus
confirming that ligation of LBP receptors had occurred. LBP did not impair the
production or measurement of peroxide since MO in LBP-coated wells exhibited
normal peroxide evolution in response to PMA (data not shown). Thus LBP receptors
appear incapable of triggering an oxidative burst.
Discussion
LBP recognizes the lipid A region of LPS and forms stoichiometric complexes
with both rough and smooth forms (10). LBP bears NH2-terminal sequence ho-
mology with another LPS-binding protein, BPI. BPI is stored in the specific granules
of PMN (12) and kills gram-negative bacteria by binding LPS and disrupting the
permeability barrier (13). In contrast to BPI, LBP is not directly cytotoxic (14) and
its precise biological function has been obscure. Here we show that LBP functions
as an opsonin since it binds bacteria and facilitates their binding and phagocytosis
by macrophages. We presume that LBP binds LPS through a domain that is homol-
ogous with the LPS-binding domain of BPI, but we predict that the attachment of
LBP to cells is mediated by a domain unique to LBP
LBP on the surface of LPS-coated particles appears to be recognized by specific
receptors on the MO which are mobile in the plane of the membrane. LBP-coated
particles bind to MO but not other blood cells, and the binding activity on the apical
surface of MO is depleted by spreading of cells on substrates coated with LBP-LPS
complexes. The receptors for LBP appear distinct from other opsonic receptors since
surface-bound antibodies to CRI, CR3, and FcR did not reduce the binding ofLBP-
coated particles. Experiments to identify the receptor for LBP are currently in progress.
The classical opsonin, IgG, facilitates the binding of IgG-coated particles, their
phagocytic engulfment, and the release of toxic compounds such as hydrogen peroxide.
The other classical opsonin, C3, facilitates principally the binding of C3-coated par-
1 .5- HSA-anti-HSA
3 w
d
x 1 .0
E 0.5t / ./"1240
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ticles. Phagocytosis by unstimulated MO is observed only if the C3-coated particles
also bear IgG (11), and evolution ofhydrogen peroxide is not initiated (15). The op-
sonic activity LBP most closely resembles that ofC3 . LBP-coated particles are avidly
boundby MO, butbindingdoes not initiate phagocytosis (Fig. 5) or release ofhydrogen
peroxide (Fig. 6). LBP also acts like C3 in that it enhances phagocytosis of particles
coated with low amounts of IgG (Fig. 5). The opsonic effect of LBP differs from
that of C3 in only one respect. While complement proteins may initiate phagocy-
tosis if MO are treated with an ancillary stimulus such as PMA (5) or fibronectin
(16), LBP does not mediate phagocytosis even in such optimally stimulated cells.
By acting as an opsonin, LBPcan be expected to limit the spread ofgram negative
bacteria in an animal . The appearance of LBP during the acute phase makes it well
suited to combating infection, and we suggest that LBP represents a defense mecha-
nism against gram negative bacteria.
Summary
Lipopolysaccharide binding protein (LBP) is an acute-phase reactant that binds
bacterial LPS. We show that LBP binds to the surface oflive Salmonella and to LPS-
coated erythrocytes (ELPS), and strongly enhances theattachment oftheseparticles
to macrophages. LBP bridges LPS-coated particles to macrophages (MO) by first
binding to the LPS, then binding to MO. Pretreatment of ELPS with LBP enabled
bindingto MO, but pretreatment of MO had no effect. Moreover, MO did not recog-
nize erythrocytes coated with LBP unless LPS was also added, thus suggesting that
interaction of LBP with LPS results in a conformational change in LBPthat allows
recognition by MO. Binding of LBP-coated particles appears to be mediated by a
receptor found on blood monocytes and MO but not on otherleukocytes or umbil-
ical vein endothelium. The receptor is mobile in the plane of the membrane since
binding activity on MO was downmodulated upon spreading of cells on surfaces
coated with LBP-LPS complexes. The receptor appears to be distinct from other
opsonic receptorssince downmodulation ofCRl, CR3, Fc7RI, FcyRI1, and FcyRIII
with mAbs did not affect bindingof LBP-coated particles, and leukocytes from CD18-
deficient patients bound LBP-coated particles normally.
Coating oferythrocytes with LBP-LPS complexes strongly enhanced phagocytosis
observed in the presence ofsuboptimal amounts of anti-erythrocyte IgG. However,
binding mediated by LBP-LPS complexes alone caused neither phagocytosis of the
LBP-coated erythrocytes norinitiation ofan oxidativeburst. Theresults of our studies
define LBP as an opsonin. During the acute phase, LBP can be expected to bind
gram-negativebacteria and bacterial fragmentsandpromote theinteraction of coated
bacteria with phagocytes.
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